2012 Q1 Form 8-K Financial Statement
#000110465912066570 Filed on October 01, 2012
Income Statement
| Concept | 2012 Q1 | 2011 Q1 |
|---|---|---|
| Revenue | $2.302B | $2.250B |
| YoY Change | 2.31% | 4.6% |
| Cost Of Revenue | $399.0M | $396.0M |
| YoY Change | 0.76% | -0.5% |
| Gross Profit | $1.903B | $1.854B |
| YoY Change | 2.64% | 5.76% |
| Gross Profit Margin | 82.67% | 82.4% |
| Selling, General & Admin | $1.099B | $1.017B |
| YoY Change | 8.06% | 3.04% |
| % of Gross Profit | 57.75% | 54.85% |
| Research & Development | ||
| YoY Change | ||
| % of Gross Profit | ||
| Depreciation & Amortization | $100.0M | $101.0M |
| YoY Change | -0.99% | 6.32% |
| % of Gross Profit | 5.25% | 5.45% |
| Operating Expenses | $1.693B | $1.581B |
| YoY Change | 7.08% | 2.0% |
| Operating Profit | $205.0M | $254.0M |
| YoY Change | -19.29% | 25.12% |
| Interest Expense | $98.00M | $118.0M |
| YoY Change | -16.95% | -209.26% |
| % of Operating Profit | 47.8% | 46.46% |
| Other Income/Expense, Net | ||
| YoY Change | ||
| Pretax Income | $108.0M | $137.0M |
| YoY Change | -21.17% | 47.31% |
| Income Tax | $42.00M | $50.00M |
| % Of Pretax Income | 38.89% | 36.5% |
| Net Earnings | $67.00M | $82.00M |
| YoY Change | -18.29% | -12.77% |
| Net Earnings / Revenue | 2.91% | 3.64% |
| Basic Earnings Per Share | $0.56 | $0.15 |
| Diluted Earnings Per Share | $0.53 | $0.14 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 102.8M shares | 486.9M shares |
| Diluted Shares Outstanding | 121.2M shares | 565.2M shares |
Balance Sheet
| Concept | 2012 Q1 | 2011 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $104.0M | $270.0M |
| YoY Change | -61.48% | -54.47% |
| Cash & Equivalents | $104.0M | $267.0M |
| Short-Term Investments | $3.000M | |
| Other Short-Term Assets | $386.0M | $708.0M |
| YoY Change | -45.48% | 73.53% |
| Inventory | $157.0M | $156.0M |
| Prepaid Expenses | ||
| Receivables | $1.417B | $1.237B |
| Other Receivables | $5.000M | $22.00M |
| Total Short-Term Assets | $2.482B | $2.393B |
| YoY Change | 3.72% | 0.29% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | $4.324B | $4.262B |
| YoY Change | 1.45% | 0.31% |
| Goodwill | $738.0M | |
| YoY Change | ||
| Intangibles | ||
| YoY Change | ||
| Long-Term Investments | $153.0M | $162.0M |
| YoY Change | -5.56% | -12.43% |
| Other Assets | $342.0M | $589.0M |
| YoY Change | -41.94% | |
| Total Long-Term Assets | $6.063B | $6.131B |
| YoY Change | -1.11% | 12.93% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $2.482B | $2.393B |
| Total Long-Term Assets | $6.063B | $6.131B |
| Total Assets | $8.545B | $8.524B |
| YoY Change | 0.25% | 9.07% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $640.0M | $638.0M |
| YoY Change | 0.31% | 3.74% |
| Accrued Expenses | $497.0M | $497.0M |
| YoY Change | 0.0% | -3.68% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | $288.0M | $68.00M |
| YoY Change | 323.53% | 3300.0% |
| Total Short-Term Liabilities | $1.840B | $1.657B |
| YoY Change | 11.04% | 4.94% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $4.295B | $4.014B |
| YoY Change | 7.0% | -6.02% |
| Other Long-Term Liabilities | $526.0M | $945.0M |
| YoY Change | -44.34% | -7.44% |
| Total Long-Term Liabilities | $526.0M | $4.959B |
| YoY Change | -89.39% | -6.29% |
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $1.840B | $1.657B |
| Total Long-Term Liabilities | $526.0M | $4.959B |
| Total Liabilities | $6.998B | $6.680B |
| YoY Change | 4.76% | -5.6% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | -$1.376B | |
| YoY Change | ||
| Common Stock | $27.00M | |
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | $1.879B | |
| YoY Change | ||
| Treasury Stock Shares | 138.1M shares | |
| Shareholders Equity | $1.460B | $1.844B |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $8.545B | $8.524B |
| YoY Change | 0.25% | 9.07% |
Cashflow Statement
| Concept | 2012 Q1 | 2011 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | $67.00M | $82.00M |
| YoY Change | -18.29% | -12.77% |
| Depreciation, Depletion And Amortization | $100.0M | $101.0M |
| YoY Change | -0.99% | 6.32% |
| Cash From Operating Activities | -$42.00M | -$2.000M |
| YoY Change | 2000.0% | -90.91% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | -$136.0M | -$116.0M |
| YoY Change | 17.24% | 39.76% |
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | -$2.000M | -$13.00M |
| YoY Change | -84.62% | -186.67% |
| Cash From Investing Activities | -$136.0M | -$129.0M |
| YoY Change | 5.43% | 89.71% |
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $26.00M | $0.00 |
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $169.0M | -$7.000M |
| YoY Change | -2514.29% | -36.36% |
| NET CHANGE | ||
| Cash From Operating Activities | -$42.00M | -$2.000M |
| Cash From Investing Activities | -$136.0M | -$129.0M |
| Cash From Financing Activities | $169.0M | -$7.000M |
| Net Change In Cash | -$9.000M | -$138.0M |
| YoY Change | -93.48% | 36.63% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$42.00M | -$2.000M |
| Capital Expenditures | -$136.0M | -$116.0M |
| Free Cash Flow | $94.00M | $114.0M |
| YoY Change | -17.54% | 86.89% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2011Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1278000000 | USD |
| CY2012Q1 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
56000000 | USD |
| CY2011Q1 | us-gaap |
Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
|
54000000 | USD |
| CY2012Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
2000000 | USD |
| CY2011Q1 | thc |
Litigation Settlements Net Of Insurance Recoveries
LitigationSettlementsNetOfInsuranceRecoveries
|
10000000 | USD |
| CY2011Q1 | thc |
Number Of Lawsuits
NumberOfLawsuits
|
2 | lawsuit |
| CY2011Q1 | us-gaap |
Insurance Recoveries
InsuranceRecoveries
|
10000000 | USD |
| CY2010Q4 | us-gaap |
Litigation Reserve
LitigationReserve
|
5000000 | USD |
| CY2012Q1 | us-gaap |
Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
|
3000000 | USD |
| CY2011Q1 | us-gaap |
Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
|
8000000 | USD |
| CY2012Q1 | thc |
Health Care Organization Revenue Cycle And Patient Communications Service Revenue
HealthCareOrganizationRevenueCycleAndPatientCommunicationsServiceRevenue
|
2392000000 | USD |
| CY2011Q1 | thc |
Health Care Organization Revenue Cycle And Patient Communications Service Revenue
HealthCareOrganizationRevenueCycleAndPatientCommunicationsServiceRevenue
|
2310000000 | USD |
| CY2012Q1 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
10000000 | USD |
| CY2012Q1 | us-gaap |
Restructuring Reserve Period Expense
RestructuringReservePeriodExpense
|
0 | USD |
| CY2012Q1 | us-gaap |
Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
|
1000000 | USD |
| CY2012Q1 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
0 | USD |
| CY2011Q1 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
15000000 | USD |
| CY2011Q1 | us-gaap |
Restructuring Reserve Period Expense
RestructuringReservePeriodExpense
|
8000000 | USD |
| CY2011Q1 | us-gaap |
Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
|
2000000 | USD |
| CY2011Q1 | us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
-1000000 | USD |
| CY2012Q1 | thc |
Cash Payments To Be Applied Against Accruals Due Within One Year
CashPaymentsToBeAppliedAgainstAccrualsDueWithinOneYear
|
3000000 | USD |
| CY2012Q1 | thc |
Cash Payments To Be Applied Against Accruals Due Thereafter
CashPaymentsToBeAppliedAgainstAccrualsDueThereafter
|
7000000 | USD |
| CY2011Q4 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
32000000 | USD |
| CY2011Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
129000000 | USD |
| CY2011Q4 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
4360000000 | USD |
| CY2011Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
66000000 | USD |
| CY2011Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
4294000000 | USD |
| CY2012Q1 | us-gaap |
Capital Lease Obligations
CapitalLeaseObligations
|
49000000 | USD |
| CY2012Q1 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
126000000 | USD |
| CY2012Q1 | us-gaap |
Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
|
4583000000 | USD |
| CY2012Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
288000000 | USD |
| CY2012Q1 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
4295000000 | USD |
| CY2012Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
|
31107224 | shares |
| CY2012Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
|
6.62 | |
| CY2012Q1 | us-gaap |
Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
|
<table style="font-size:10pt; font-family:'Times New Roman',times,serif;"> <tr> <td> <p style="MARGIN: 0in 0in 0pt"><b><i><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman" size="2">Net Operating Revenues</font></i></b><b><i><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic" size="2"> Before Provision for Doubtful Accounts</font></i></b></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">We recognize net operating revenues before provision for doubtful accounts in the period in which our services are performed. Net operating revenues before provision for doubtful accounts primarily consist of net patient service revenues that are recorded based on established billing rates (i.e., gross charges), less estimated discounts for contractual and other allowances, principally for patients covered by Medicare, Medicaid, managed care and other health plans, as well as certain uninsured patients under our</font><font style="FONT-SIZE: 10pt" size="2"> <i>Compact with Uninsured Patients </i>(“Compact”).</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <p style="MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">The table below shows the sources of net operating revenues before provision for doubtful accounts from continuing operations:</font></p> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p> <table style="WIDTH: 96.66%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0" width="96%" border="0"> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1"> </font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1"> </font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 27.42%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="27%" colspan="5"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">Three Months Ended<br />  March 31,</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1"> </font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1"> </font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1"> </font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.42%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">2012</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1"> </font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.42%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman" size="1">2011</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: center" align="center"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="1"> </font></b></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Medicare </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.34%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.08%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">629</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.34%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.08%; PADDING-TOP: 0in; BORDER-BOTTOM: medium none" valign="bottom" width="11%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">542</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Medicaid </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.42%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">177</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.42%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">269</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Managed care </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 12.42%; PADDING-TOP: 0in" valign="bottom" width="12%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">1,326</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 12.42%; PADDING-TOP: 0in" valign="bottom" width="12%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">1,279</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Indemnity, self-pay and other </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.42%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">241</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 12.42%; PADDING-TOP: 0in" valign="bottom" width="12%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">249</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Acute care hospitals — other revenue </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 12.42%; PADDING-TOP: 0in" valign="bottom" width="12%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">24</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 12.42%; PADDING-TOP: 0in" valign="bottom" width="12%" bgcolor="#CCEEFF" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">25</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Other operations </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.42%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">94</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 12.42%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 1pt solid" valign="bottom" width="12%" colspan="2"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">65</font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%"> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr> <tr style="HEIGHT: 0px"> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 68.96%; PADDING-TOP: 0in" valign="bottom" width="68%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt 10pt; TEXT-INDENT: -10pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">Net operating revenues before provision for doubtful accounts</font></b><font style="FONT-SIZE: 10pt" size="2"> </font></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.34%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.08%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">2,491</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 2.58%; PADDING-TOP: 0in" valign="bottom" width="2%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: medium none; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 1.34%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">$</font></b></p></td> <td style="BORDER-RIGHT: medium none; PADDING-RIGHT: 0in; BORDER-TOP: windowtext 1pt solid; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; BORDER-LEFT: medium none; WIDTH: 11.08%; PADDING-TOP: 0in; BORDER-BOTTOM: windowtext 2.25pt double" valign="bottom" width="11%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt; TEXT-ALIGN: right" align="right"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2">2,429</font></b></p></td> <td style="PADDING-RIGHT: 0in; PADDING-LEFT: 0in; BACKGROUND: #cceeff; PADDING-BOTTOM: 0in; WIDTH: 1.04%; PADDING-TOP: 0in" valign="bottom" width="1%" bgcolor="#CCEEFF"> <p style="MARGIN: 0in 0in 0pt"><b><font style="FONT-WEIGHT: bold; FONT-SIZE: 1pt; FONT-FAMILY: Times New Roman" size="2"> </font></b></p></td></tr></table> <p style="MARGIN: 0in 0in 0pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman" size="2"> </font></p></td></tr></table> | |
| CY2012Q1 | thc |
Number Of Hospitals Operated By Subsidiaries
NumberOfHospitalsOperatedBySubsidiaries
|
50 | hospital |
| CY2012Q1 | thc |
Number Of Academic Medical Centers Operated By Subsidiaries
NumberOfAcademicMedicalCentersOperatedBySubsidiaries
|
4 | center |
| CY2012Q1 | thc |
Number Of Critical Access Hospitals Operated By Subsidiaries
NumberOfCriticalAccessHospitalsOperatedBySubsidiaries
|
1 | hospital |
| CY2012Q1 | thc |
Number Of Licensed Beds In Hospitals Operated By Subsidiaries
NumberOfLicensedBedsInHospitalsOperatedBySubsidiaries
|
13509 | bed |
| CY2012Q1 | thc |
Number Of States In Which Subsidiaries Of Entity Operate Hospitals
NumberOfStatesInWhichSubsidiariesOfEntityOperateHospitals
|
11 | state |
| CY2012Q1 | thc |
Number Of Free Standing And Provider Based Diagnostic Imaging Centers And Ambulatory Surgery Centers Operated By Subsidiaries
NumberOfFreeStandingAndProviderBasedDiagnosticImagingCentersAndAmbulatorySurgeryCentersOperatedBySubsidiaries
|
101 | center |
| CY2012Q1 | thc |
Health Care Organization Revenue Gross
HealthCareOrganizationRevenueGross
|
2491000000 | USD |
| CY2012Q1 | thc |
Cash And Cash Equivalents Maturity Period
CashAndCashEquivalentsMaturityPeriod
|
3 | |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
104000000 | USD |
| CY2011Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
113000000 | USD |
| CY2012Q1 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
186000000 | USD |
| CY2011Q4 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
252000000 | USD |
| CY2012Q1 | thc |
Cash And Cash Equivalents Related To Captive Insurance Subsidiaries
CashAndCashEquivalentsRelatedToCaptiveInsuranceSubsidiaries
|
83000000 | USD |
| CY2011Q4 | thc |
Cash And Cash Equivalents Related To Captive Insurance Subsidiaries
CashAndCashEquivalentsRelatedToCaptiveInsuranceSubsidiaries
|
92000000 | USD |
| CY2011Q1 | thc |
Repatriated Cash From Subsidiaries
RepatriatedCashFromSubsidiaries
|
21000000 | USD |
| CY2012Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
51000000 | USD |
| CY2011 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
109000000 | USD |
| CY2012Q1 | thc |
Capital Expenditures Incurred But Not Yet Paid Current
CapitalExpendituresIncurredButNotYetPaidCurrent
|
45000000 | USD |
| CY2011Q4 | thc |
Capital Expenditures Incurred But Not Yet Paid Current
CapitalExpendituresIncurredButNotYetPaidCurrent
|
104000000 | USD |
| CY2012Q1 | us-gaap |
Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
|
17000000 | USD |
| CY2012Q1 | us-gaap |
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
|
33035209 | shares |
| CY2012Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm1
|
5.1 | |
| CY2012Q1 | us-gaap |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
|
6.55 | |
| CY2011Q2 | us-gaap |
Stock Repurchase Program Authorized Amount
StockRepurchaseProgramAuthorizedAmount
|
400000000 | USD |
| us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
75766000 | shares | |
| us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
4.94 | ||
| CY2012Q1 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
5308000 | shares |
| CY2012Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
4.93 | |
| CY2012Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
|
0 | USD |
| us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
|
26000000 | USD | |
| CY2012Q1 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
81074000 | shares |
| CY2012Q1 | us-gaap |
Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
|
4.94 | |
| CY2012Q1 | us-gaap |
Stock Repurchase Program Remaining Authorized Repurchase Amount
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount
|
0 | USD |
| CY2012Q1 | thc |
Stock Repurchase Program Expiration Date
StockRepurchaseProgramExpirationDate
|
09-May-12 | |
| CY2012Q1 | us-gaap |
Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
|
28000000 | USD |
| CY2011Q1 | us-gaap |
Malpractice Loss Contingency Claims Incurred Net
MalpracticeLossContingencyClaimsIncurredNet
|
27000000 | USD |
| CY2012Q1 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
35000000 | USD |
| CY2012Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
200000 | USD |
| CY2012Q1 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
10000000 | USD |
| CY2012Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
411373000 | shares |
| CY2012Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.14 | |
| CY2012Q1 | us-gaap |
Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
|
6000000 | USD |
| CY2012Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
73500000 | shares |
| CY2012Q1 | thc |
Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount
EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount
|
-0.01 | |
| CY2012Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
63000000 | USD |
| CY2012Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
484873000 | shares |
| CY2012Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.13 | |
| CY2012Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15316000 | shares |
| CY2012Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
57000000 | USD |
| CY2011Q1 | us-gaap |
Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
|
6000000 | USD |
| CY2011Q1 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
78279000 | shares |
| CY2011Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
86000000 | USD |
| CY2011Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
18753000 | shares |
| CY2012Q1 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
58000000 | USD |
| CY2012Q1 | us-gaap |
Loss Contingency Accrual Carrying Value Payments
LossContingencyAccrualCarryingValuePayments
|
10000000 | USD |
| CY2011Q1 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
35000000 | USD |
| CY2011Q1 | us-gaap |
Loss Contingency Accrual Carrying Value Payments
LossContingencyAccrualCarryingValuePayments
|
6000000 | USD |
| CY2010Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
30000000 | USD |
| CY2012Q1 | thc |
Estimated Fair Value Of Debt Instrument As Percentage Of Carrying Value
EstimatedFairValueOfDebtInstrumentAsPercentageOfCarryingValue
|
1.055 | pure |
| CY2011Q4 | thc |
Estimated Fair Value Of Debt Instrument As Percentage Of Carrying Value
EstimatedFairValueOfDebtInstrumentAsPercentageOfCarryingValue
|
1.049 | pure |
| CY2012Q1 | thc |
Preferred Stock And Other Securities Held By Captive Insurance Subsidiaries
PreferredStockAndOtherSecuritiesHeldByCaptiveInsuranceSubsidiaries
|
1000000 | USD |
| CY2012Q1 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
1000000 | USD |
| CY2012Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
TENET HEALTHCARE CORP | |
| CY2012Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000070318 | |
| CY2012Q1 | dei |
Document Type
DocumentType
|
8-K | |
| CY2012Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2012-03-31 | |
| CY2012Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2012Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2012Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8545000000 | USD |
| CY2012Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1531000000 | USD |
| CY2012Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1460000000 | USD |
| CY2012Q1 | us-gaap |
Liabilities
Liabilities
|
6998000000 | USD |
| CY2012Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1840000000 | USD |
| CY2012Q1 | us-gaap |
Assets
Assets
|
8545000000 | USD |
| CY2012Q1 | us-gaap |
Assets Current
AssetsCurrent
|
2482000000 | USD |
| CY2012Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
380000000 | USD |
| CY2012Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3442000000 | USD |
| CY2012Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
375000000 | USD |
| CY2012Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.15 | |
| CY2012Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2500000 | shares |
| CY2012Q1 | thc |
Percentage Of Mandatory Convertible Shares
PercentageOfMandatoryConvertibleShares
|
0.07 | pure |
| CY2012Q1 | thc |
Preferred Stock Seven Percent Mandatory Convertible Shares Issued
PreferredStockSevenPercentMandatoryConvertibleSharesIssued
|
345000 | shares |
| CY2012Q1 | us-gaap |
Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
|
1000 | |
| CY2012Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.05 | |
| CY2012Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1050000000 | shares |
| CY2012Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
551631747 | shares |
| CY2012Q1 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
138100420 | shares |
| CY2011Q1 | us-gaap |
Profit Loss
ProfitLoss
|
82000000 | USD |
| CY2011Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
98000000 | USD |
| CY2011Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
179000000 | USD |
| CY2011Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
35000000 | USD |
| CY2011Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
7000000 | USD |
| CY2011Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
-19000000 | USD |
| CY2011Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
8000000 | USD |
| CY2011Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-11000000 | USD |
| CY2011Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
|
-10000000 | USD |
| CY2011Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
11000000 | USD |
| CY2011Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
277000000 | USD |
| CY2011Q1 | thc |
Increase Decrease In Inventories And Other Assets Current
IncreaseDecreaseInInventoriesAndOtherAssetsCurrent
|
109000000 | USD |
| CY2011Q1 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
14000000 | USD |
| CY2011Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-42000000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-109000000 | USD |
| CY2011Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
12000000 | USD |
| CY2011Q1 | thc |
Payments For Restructuring And Litigation Costs
PaymentsForRestructuringAndLitigationCosts
|
7000000 | USD |
| CY2011Q1 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-11000000 | USD |
| CY2011Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2000000 | USD |
| CY2011Q1 | thc |
Payments To Acquire Property Plant And Equipment For Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentForContinuingOperations
|
116000000 | USD |
| CY2011Q1 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
18000000 | USD |
| CY2011Q1 | thc |
Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets
ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets
|
5000000 | USD |
| CY2011Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-129000000 | USD |
| CY2012Q1 | us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
658000000 | USD |
| CY2011Q1 | us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
1000000 | USD |
| CY2011Q1 | us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
6000000 | USD |
| CY2011Q1 | us-gaap |
Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
|
2000000 | USD |
| CY2011Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
2000000 | USD |
| CY2012Q1 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
455000000 | USD |
| CY2011Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-7000000 | USD |
| CY2011Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-138000000 | USD |
| CY2011Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
-97000000 | USD |
| CY2011Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
-24000000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-42000000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-136000000 | USD |
| CY2012Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
169000000 | USD |
| CY2011Q4 | us-gaap |
Inventory Net
InventoryNet
|
161000000 | USD |
| CY2011Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
7000000 | USD |
| CY2011Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
418000000 | USD |
| CY2011Q4 | us-gaap |
Assets Held For Sale Current
AssetsHeldForSaleCurrent
|
2000000 | USD |
| CY2011Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
378000000 | USD |
| CY2011Q4 | us-gaap |
Assets Current
AssetsCurrent
|
2357000000 | USD |
| CY2011Q4 | us-gaap |
Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
|
156000000 | USD |
| CY2011Q4 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
374000000 | USD |
| CY2011Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4350000000 | USD |
| CY2011Q4 | us-gaap |
Goodwill
Goodwill
|
736000000 | USD |
| CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
489000000 | USD |
| CY2011Q4 | us-gaap |
Assets
Assets
|
8462000000 | USD |
| CY2011Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
760000000 | USD |
| CY2011Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
376000000 | USD |
| CY2011Q4 | us-gaap |
Self Insurance Reserve Current
SelfInsuranceReserveCurrent
|
75000000 | USD |
| CY2011Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
112000000 | USD |
| CY2011Q4 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
64000000 | USD |
| CY2011Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
362000000 | USD |
| CY2011Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1815000000 | USD |
| CY2011Q4 | us-gaap |
Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
|
337000000 | USD |
| CY2011Q4 | us-gaap |
Litigation Reserve Noncurrent
LitigationReserveNoncurrent
|
2000000 | USD |
| CY2011Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
506000000 | USD |
| CY2011Q4 | us-gaap |
Liabilities
Liabilities
|
6954000000 | USD |
| CY2011Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2011Q4 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
16000000 | USD |
| CY2011Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
334000000 | USD |
| CY2011Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
27000000 | USD |
| CY2011Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
4407000000 | USD |
| CY2011Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-52000000 | USD |
| CY2011Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1440000000 | USD |
| CY2011Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
1853000000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
1423000000 | USD |
| CY2011Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.05 | |
| CY2011Q4 | us-gaap |
Minority Interest
MinorityInterest
|
69000000 | USD |
| CY2011Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1492000000 | USD |
| CY2011Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
8462000000 | USD |
| CY2011Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
267000000 | USD |
| CY2012Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax Period Increase Decrease
OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
0 | USD |
| CY2012Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
|
3000000 | USD |
| CY2011Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
82000000 | USD |
| CY2011Q1 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
6000000 | USD |
| CY2011Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
3000000 | USD |
| CY2011Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
73000000 | USD |
| CY2012Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
61000000 | USD |
| CY2011Q1 | thc |
Health Care Organization Revenue Gross
HealthCareOrganizationRevenueGross
|
2429000000 | USD |
| CY2011Q1 | us-gaap |
Health Care Organization Revenue
HealthCareOrganizationRevenue
|
2250000000 | USD |
| CY2011Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
1017000000 | USD |
| CY2011Q1 | us-gaap |
Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
|
396000000 | USD |
| CY2011Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
491000000 | USD |
| CY2011Q1 | thc |
Electronic Health Record Incentives
ElectronicHealthRecordIncentives
|
-25000000 | USD |
| CY2011Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
254000000 | USD |
| CY2011Q1 | us-gaap |
Interest Expense
InterestExpense
|
118000000 | USD |
| CY2011Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
1000000 | USD |
| CY2011Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
137000000 | USD |
| CY2011Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
50000000 | USD |
| CY2011Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
87000000 | USD |
| CY2011Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
|
-10000000 | USD |
| CY2011Q1 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
-5000000 | USD |
| CY2011Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
-5000000 | USD |
| CY2011Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
3000000 | USD |
| CY2011Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
73000000 | USD |
| CY2011Q1 | us-gaap |
Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
|
80000000 | USD |
| CY2011Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
-7000000 | USD |
| CY2011Q1 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.16 | |
| CY2011Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.01 | |
| CY2011Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.15 | |
| CY2011Q1 | us-gaap |
Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
|
0.15 | |
| CY2011Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
-0.01 | |
| CY2011Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.14 | |
| CY2011Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
486902000 | shares |
| CY2011Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
565181000 | shares |
| CY2011Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
397000000 | USD |
| CY2011Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3386000000 | USD |
| CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
360000000 | USD |
| CY2011Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
1050000000 | shares |
| CY2011Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
551468550 | shares |
| CY2011Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
136442696 | shares |
| CY2012Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
58000000 | USD |
| CY2012Q1 | us-gaap |
Profit Loss
ProfitLoss
|
67000000 | USD |
| CY2012Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.00 | |
| CY2012Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.14 | |
| CY2012Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
0.00 | |
| CY2012Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.13 | |
| CY2012Q1 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
70000000 | USD |
| CY2012Q1 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-9000000 | USD |
| CY2010Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
405000000 | USD |
| CY2010Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1819000000 | USD |
| CY2011Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
1908000000 | USD |
| CY2011Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
5000000 | USD |
| CY2011Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
10000000 | USD |
| CY2011Q1 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
2000000 | USD |
| CY2012Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
2000000 | USD |
| CY2012Q1 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
6000000 | USD |
| CY2012Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
400000000 | USD |
| CY2011Q4 | us-gaap |
Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
|
66000000 | USD |
| CY2010Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
10000000 | USD |
| CY2012Q1 | us-gaap |
Finite Lived Intangible Assets Future Amortization Expense
FiniteLivedIntangibleAssetsFutureAmortizationExpense
|
506000000 | USD |
| CY2012Q1 | us-gaap |
Future Amortization Expense Remainder Of Fiscal Year
FutureAmortizationExpenseRemainderOfFiscalYear
|
56000000 | USD |
| CY2012Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
881000000 | USD |
| CY2011Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
849000000 | USD |
| CY2011Q1 | thc |
Effect Of Dilutive Stock Options Restricted Stock Units And Mandatory Convertible Preferred Stock Per Share Amount
EffectOfDilutiveStockOptionsRestrictedStockUnitsAndMandatoryConvertiblePreferredStockPerShareAmount
|
-0.01 | |
| CY2012Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
506000000 | USD |
| CY2011Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
11000000 | USD |
| CY2012Q1 | us-gaap |
Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
|
9000000 | USD |
| CY2012Q1 | us-gaap |
Future Amortization Expense Year Two
FutureAmortizationExpenseYearTwo
|
69000000 | USD |
| CY2012Q1 | us-gaap |
Future Amortization Expense Year Three
FutureAmortizationExpenseYearThree
|
65000000 | USD |
| CY2012Q1 | us-gaap |
Future Amortization Expense Year Four
FutureAmortizationExpenseYearFour
|
55000000 | USD |
| CY2012Q1 | us-gaap |
Future Amortization Expense Year Five
FutureAmortizationExpenseYearFive
|
52000000 | USD |
| CY2012Q1 | us-gaap |
Future Amortization Expense After Year Five
FutureAmortizationExpenseAfterYearFive
|
209000000 | USD |
| CY2012Q1 | us-gaap |
Inventory Net
InventoryNet
|
157000000 | USD |
| CY2012Q1 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
5000000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
411000000 | USD |
| CY2012Q1 | us-gaap |
Assets Held For Sale Current
AssetsHeldForSaleCurrent
|
2000000 | USD |
| CY2012Q1 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
386000000 | USD |
| CY2012Q1 | us-gaap |
Long Term Investments And Receivables Net
LongTermInvestmentsAndReceivablesNet
|
153000000 | USD |
| CY2012Q1 | us-gaap |
Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
|
342000000 | USD |
| CY2012Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
4324000000 | USD |
| CY2012Q1 | us-gaap |
Goodwill
Goodwill
|
738000000 | USD |
| CY2012Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
640000000 | USD |
| CY2012Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
338000000 | USD |
| CY2012Q1 | us-gaap |
Self Insurance Reserve Current
SelfInsuranceReserveCurrent
|
63000000 | USD |
| CY2012Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
103000000 | USD |
| CY2012Q1 | us-gaap |
Litigation Reserve Current
LitigationReserveCurrent
|
56000000 | USD |
| CY2012Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
352000000 | USD |
| CY2012Q1 | us-gaap |
Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
|
335000000 | USD |
| CY2012Q1 | us-gaap |
Litigation Reserve Noncurrent
LitigationReserveNoncurrent
|
2000000 | USD |
| CY2012Q1 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
526000000 | USD |
| CY2012Q1 | us-gaap |
Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
-16000000 | USD |
| CY2012Q1 | us-gaap |
Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
|
16000000 | USD |
| CY2012Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
334000000 | USD |
| CY2012Q1 | us-gaap |
Gain Loss On Investments
GainLossOnInvestments
|
1000000 | USD |
| CY2012Q1 | thc |
Payments To Acquire Property Plant And Equipment For Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentForContinuingOperations
|
136000000 | USD |
| CY2012Q1 | us-gaap |
Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
108000000 | USD |
| CY2012Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
42000000 | USD |
| CY2012Q1 | us-gaap |
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
66000000 | USD |
| CY2012Q1 | thc |
Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets
ProceedsFromSaleOfMarketableSecuritiesLongTermInvestmentsAndOtherAssets
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
|
4000000 | USD |
| CY2012Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
26000000 | USD |
| CY2012Q1 | us-gaap |
Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
|
2000000 | USD |
| CY2012Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
|
1000000 | USD |
| CY2012Q1 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
|
1000000 | USD |
| CY2012Q1 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
1879000000 | USD |
| CY2012Q1 | us-gaap |
Minority Interest
MinorityInterest
|
71000000 | USD |
| CY2012Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
189000000 | USD |
| CY2012Q1 | us-gaap |
Health Care Organization Revenue
HealthCareOrganizationRevenue
|
2302000000 | USD |
| CY2012Q1 | us-gaap |
Labor And Related Expense
LaborAndRelatedExpense
|
1062000000 | USD |
| CY2012Q1 | us-gaap |
Health Care Organization Medical Supplies And Drugs Expense
HealthCareOrganizationMedicalSuppliesAndDrugsExpense
|
399000000 | USD |
| CY2012Q1 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
531000000 | USD |
| CY2012Q1 | thc |
Electronic Health Record Incentives
ElectronicHealthRecordIncentives
|
0 | USD |
| CY2012Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
100000000 | USD |
| CY2012Q1 | us-gaap |
Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
|
-2000000 | USD |
| CY2012Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
205000000 | USD |
| CY2012Q1 | us-gaap |
Interest Expense
InterestExpense
|
98000000 | USD |
| CY2012Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecrease
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
38000000 | USD |
| CY2012Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
8000000 | USD |
| CY2012Q1 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
5000000 | USD |
| CY2012Q1 | us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
324000000 | USD |
| CY2012Q1 | thc |
Increase Decrease In Inventories And Other Assets Current
IncreaseDecreaseInInventoriesAndOtherAssetsCurrent
|
8000000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
-3000000 | USD |
| CY2012Q1 | us-gaap |
Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
|
16000000 | USD |
| CY2012Q1 | thc |
Payments For Restructuring And Litigation Costs
PaymentsForRestructuringAndLitigationCosts
|
11000000 | USD |
| CY2012Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
27000000 | USD |
| CY2012Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
4403000000 | USD |
| CY2012Q1 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
-49000000 | USD |
| CY2012Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1376000000 | USD |
| CY2012Q1 | us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
6000000 | USD |
| CY2012Q1 | us-gaap |
Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
|
3000000 | USD |
| CY2012Q1 | us-gaap |
Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
|
5000000 | USD |
| CY2012Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
-102000000 | USD |
| CY2012Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
-2000000 | USD |
| CY2012Q1 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
1000000 | USD |
| CY2012Q1 | us-gaap |
Minority Interest Increase From Stock Issuance
MinorityInterestIncreaseFromStockIssuance
|
2000000 | USD |
| CY2011Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.15 | |
| CY2011Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2500000 | shares |
| CY2011Q4 | thc |
Percentage Of Mandatory Convertible Shares
PercentageOfMandatoryConvertibleShares
|
0.07 | pure |
| CY2011Q4 | thc |
Preferred Stock Seven Percent Mandatory Convertible Shares Issued
PreferredStockSevenPercentMandatoryConvertibleSharesIssued
|
345000 | shares |
| CY2011Q4 | us-gaap |
Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
|
1000 | |
| CY2011 | thc |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | segment |
| CY2012Q1 | thc |
Number Of Hospitals Owned By Subsidiaries
NumberOfHospitalsOwnedBySubsidiaries
|
49 | hospital |
| CY2012Q1 | thc |
Number Of Academic Medical Centers Operated By The Subsidiaries
NumberOfAcademicMedicalCentersOperatedByTheSubsidiaries
|
3 | center |
| CY2012Q1 | thc |
Number Of Licensed Beds In Hospitals Operated By The Subsidiaries
NumberOfLicensedBedsInHospitalsOperatedByTheSubsidiaries
|
13175 | bed |
| CY2012Q1 | thc |
Number Of States In Which Subsidiaries Operate Hospitals
NumberOfStatesInWhichSubsidiariesOperateHospitals
|
10 | state |
| CY2012Q1 | thc |
Number Of Free Standing And Provider Based Diagnostic Imaging Centers And Ambulatory Surgery Centers Operated By Subsidiaries Excluding Classified In Discontinued Operations
NumberOfFreeStandingAndProviderBasedDiagnosticImagingCentersAndAmbulatorySurgeryCentersOperatedBySubsidiariesExcludingClassifiedInDiscontinuedOperations
|
98 | center |
| CY2012Q1 | thc |
Number Of Hospitals To Which Segment Of The Entity Provides Revenue Cycle Services
NumberOfHospitalsToWhichSegmentOfTheEntityProvidesRevenueCycleServices
|
300 | hospital |
| CY2012Q1 | thc |
Capital Expenditure
CapitalExpenditure
|
136000000 | USD |
| CY2011Q1 | thc |
Capital Expenditure
CapitalExpenditure
|
116000000 | USD |
| CY2011Q1 | us-gaap |
Revenues From Transactions With Other Operating Segments Of Same Entity
RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity
|
-60000000 | USD |
| CY2012Q1 | us-gaap |
Revenues From Transactions With Other Operating Segments Of Same Entity
RevenuesFromTransactionsWithOtherOperatingSegmentsOfSameEntity
|
-90000000 | USD |
| CY2012Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
3000000 | USD |
| CY2012Q1 | thc |
Adjusted Earnings Before Income Tax
AdjustedEarningsBeforeIncomeTax
|
108000000 | USD |
| CY2011Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
8000000 | USD |
| CY2011Q1 | thc |
Adjusted Earnings Before Income Tax
AdjustedEarningsBeforeIncomeTax
|
137000000 | USD |
| CY2012Q1 | us-gaap |
Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
|
0 | USD |
| CY2011Q1 | us-gaap |
Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
|
0 | USD |
| CY2011Q1 | us-gaap |
Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
|
0 | USD |
| CY2011Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | USD |
| CY2012Q1 | thc |
Adjusted Proforma Earnings Before Interest Tax Depreciation And Amortization
AdjustedProformaEarningsBeforeInterestTaxDepreciationAndAmortization
|
310000000 | USD |
| CY2011Q1 | thc |
Adjusted Proforma Earnings Before Interest Tax Depreciation And Amortization
AdjustedProformaEarningsBeforeInterestTaxDepreciationAndAmortization
|
371000000 | USD |
| CY2012Q1 | thc |
Adjusted Earnings Before Interest Tax Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization
|
310000000 | USD |
| CY2011Q1 | thc |
Adjusted Earnings Before Interest Tax Depreciation And Amortization
AdjustedEarningsBeforeInterestTaxDepreciationAndAmortization
|
371000000 | USD |
| CY2011Q1 | us-gaap |
Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecrease
|
0 | USD |
| CY2011Q1 | us-gaap |
Other Comprehensive Income Loss Before Tax Period Increase Decrease
OtherComprehensiveIncomeLossBeforeTaxPeriodIncreaseDecrease
|
0 | USD |
| CY2011Q1 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
0 | USD |
| CY2011Q1 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
|
0 | USD |
| CY2012Q1 | thc |
Number Of Hospitals Classified In Discontinued Operations
NumberOfHospitalsClassifiedInDiscontinuedOperations
|
1 | hospital |
| CY2012Q1 | thc |
Number Of Free Standing And Provider Based Diagnostic Imaging Centers And Ambulatory Surgery Centers Classified In Discontinued Operations
NumberOfFreeStandingAndProviderBasedDiagnosticImagingCentersAndAmbulatorySurgeryCentersClassifiedInDiscontinuedOperations
|
3 | center |
| CY2012Q1 | thc |
Number Of States In Which Free Standing And Provider Based Diagnostic Imaging Centers And Ambulatory Surgery Centers Operated By Subsidiaries
NumberOfStatesInWhichFreeStandingAndProviderBasedDiagnosticImagingCentersAndAmbulatorySurgeryCentersOperatedBySubsidiaries
|
12 | state |
| CY2012Q1 | thc |
Number Of States In Which Free Standing And Provider Based Diagnostic Imaging Centers And Ambulatory Surgery Centers Operated By Subsidiaries For Continuing Operations
NumberOfStatesInWhichFreeStandingAndProviderBasedDiagnosticImagingCentersAndAmbulatorySurgeryCentersOperatedBySubsidiariesForContinuingOperations
|
11 | state |
